NeuroSense Therapeutics (NRSN) Q1 2025 Earnings
NRSN·Reported May 28, 2025·Before market open
Diluted EPS came in at $-0.11, missed the $-0.10 consensus by $0.01.
Diluted EPS
$-0.11missed by $0.01
Consensus: $-0.10
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2025 Earnings FAQ
Common questions about NeuroSense Therapeutics's Q1 2025 earnings report.
NeuroSense Therapeutics (NRSN) reported Q1 2025 earnings on May 28, 2025 before market open.
NeuroSense Therapeutics reported diluted EPS of $-0.11 for Q1 2025.
EPS missed the consensus estimate of $-0.10 by $0.01.